Eva G Katz

Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma.

Bortezomib, melphalan, and prednisone with or without daratumumab in transplant-ineligible patiënten met newly diagno...

PROs na cilta-cel versus standaard bij lenalidomide-refractair myeloom: CARTITUDE-4 analyse